Robinhood Markets Inc. (HOOD)

Robinhood Markets Inc. (HOOD) is trading near the bottom of its 52-week range and well under its moving averages, after a fall of 36.08% over the past year. The stock sits 9.30% below its 200-day average and 21.06% below its 50-day average, and the CleaRank score of 39 out of 100 reflects that weak trend alongside a valuation that prices in a large premium to peers. Analysts remain constructive, with 26 of 32 ratings at Buy or Strong Buy, which is the main reason the stock is not rated lower.

Robinhood missed the analysts' EPS estimate in its October 27, 2026 report, with adjusted EPS of $0.51 against $0.55 expected, a shortfall of 7.27%. The shares fell 3.31% in the first session after that report. The earnings record over the last five reports shows three beats, and in each of those three cases the share price fell in the first session after the report. The stock has therefore traded lower after results even when earnings beat, so investors are reacting to more than the headline EPS figure.

The trailing P/E is 38.40, a premium to peers and 132.7% above the Financial Services sector median of 16.5. The price-to-sales ratio of 14.76 is 288.4% above the sector median of 3.8. Trailing GAAP EPS is $2.17, so the multiple is high on reported earnings.

The net profit margin is 39.04% and the operating margin is 48.10%. Return on equity is 21.45%, above the sector median of 13.8%. The debt-to-equity ratio of 2.24 is a higher figure, though for a bank it leaves out deposits, and Robinhood is not a bank. These strengths are the reason the company earns a health score of 4 out of 5.

Insiders sold $1.9B of stock over the last 18 months across 96 sales, while open-market purchases totalled $57.3M across 4 purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than open-market purchases, but the scale of selling is a factor that weighs on sentiment.

The base case for the coming months is that HOOD stays volatile and range-bound below its moving averages until the price can reclaim the 200-day and 20-day averages and then hold above them. Analysts expect earnings per share to rise 2.3% this fiscal year to $2.10 and 39.7% next year to $2.93, so the bull case depends on those estimates holding through the next reports. The analysts' median 12-month target of $132.00 sits 58.4% above the current price, while the lowest target is $59.00 and the highest is $170.00. A further miss against estimates, like the one in the October 27, 2026 report, or another sharp post-earnings sell-off would weaken the case and push the price toward the 52-week low. With a beta of 2.53, the stock can swing far more than the broad market in either direction.

Support sits at the 52-week low of $63.52, the level a further fall would meet first. Resistance is nearest at the 200-day average of $91.87, followed closely by the 20-day exponential average of $91.89, which together form a single resistance zone just above the price. The next level above the price is the 200-day average at $91.87, then the 20-day EMA at $91.89, the 50-day average at $105.55, and the 52-week high of $139.75. The price is below all of the moving averages, so the 200-day and 20-day averages are the first hurdles for any recovery.